FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

PFIZER

4,184.9
+211.15 (5.31%)
Updated 03:29 02/07 IST

PFIZER Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for PFIZER
Disclaimer
0% Bullish
0% Bearish

PFIZER Buy or Sell - Brokerage Reports

No. of reports in last year
2
No. of analysts
2
Average Consensus Forecast
3978
Consensus Potential
-4.07%
See PFIZER Share Price Targets >>

PFIZER Ratings

Long term PFIZER rating by FrontPage users
4.5/5 (2 Ratings)
Find answers to all your questions on live PFIZER message board: Is PFIZER buy or sell? Should I buy PFIZER shares? Why are PFIZER shares falling? Should I invest in PFIZER stock?

  1. Home
  2. PFIZER Forum

PFIZER Share Price Discussion

N
Reputation: 3,789 • Today 8:06 AM
Rupee posts biggest single day gain against dollar since April 23
The dollar index, which gauges the greenback's strength against a basket of six currencies, fell 0.35 per cent to 96.85.
The Economic Times
Like
Reply

Type
Sell
Instrument
PFIZER
Entry Price
₹4,136
Price@Trade
₹4,136
Target Price
₹3,863.7
Stop Price
₹4,265.55
Valid Till
Jul 2, 2020 3:20 AM
Margin
₹99,264 approx for 24 Qty
Status
Active
Like
Reply

Type
Sell
Instrument
PFIZER
Entry Price
₹4,166.1
Price@Trade
₹4,166.1
Target Price
₹3,912.1
Stop Price
₹4,285.45
Valid Till
Jul 2, 2020 3:20 AM
Margin
₹99,986.4 approx for 24 Qty
Status
Active
Like
Reply
L
Reputation: -1,273 • Today 5:07 AM

PFIZER - chart - 975846
Pfizer chart NSE VS NYSE after vaccine news
Like
Reply
N
Reputation: 3,789 • Today 3:11 AM
Gold prices today ease amid upbeat economic data, optimism over vaccine
A Covid-19 vaccine developed by German biotech firm BioNTech and US pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials.
The Economic Times
Like
Reply
N
Reputation: 3,789 • Today 2:36 AM
Asian stocks rise on vaccine hopes, eyes on US payrolls
Japan's Nikkei rose 0.4%, China's blue-chip index added 0.6% while Hong Kong's Hang Seng index climbed 1.7%.
The Economic Times
Like
Reply
N
Reputation: 3,789 • Today 1:26 AM
Dollar on defensive as upbeat data dulls safe-haven appeal
The euro changed hands at $1.1252, maintaining its gain of 0.3% since the start of week.
The Economic Times
Like
Reply
N
Reputation: 3,789 • Yesterday 5:01 AM
BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial
The drug is one of 17 being tested on humans in a frantic global race to find a vaccine the world is counting on to end a pandemic that has infected 10.5 million people and killed more than half a million so far. No COVID-19 vaccine has yet been approved for commercial use.
The Economic Times
Like
Reply
Pfizer stock jumps after it reports positive data in early stage coronavirus vaccine trial
Pfizer shares jumped after it released positive results from its closely watched early-stage human trial on a coronavirus vaccine.
CNBC
5
Reply

Positional Cash:

☑️Buy Pfizer CMP 4064

Target 4230/4400/4570++

SL 3940 CLBS

Like
Reply

Type
Buy
Instrument
PFIZER
Entry Price
₹4,081
Price@Trade
₹4,080
Target Price
₹4,444
Stop Price
₹3,800
Valid Till
Jul 24, 2020 3:20 AM
Margin
₹204,050 approx for 50 Qty
Status
Exited
Exit Price
₹4,212.95
Net P&L
+₹6,597.5 (+3.23%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Jun 25 8:15 AM

Update
Trade Entered
Entry Price
₹4,081

Update
Exited
Exit Price
₹4,212.95
Net P&L
+₹6,597.5 (+3.23%)
R
Reputation: -154 • Jun 25 8:08 AM

Type
Buy
Instrument
PFIZER
Entry Price
₹4,040  ₹4,036.15
Price@Trade
₹4,074
Target Price
₹4,350
Stop Price
₹3,940
Valid Till
Jul 2, 2020 3:20 AM
Margin
₹4,036.15 approx for 1 Qty
Status
Exited
Exit Price
₹4,176.1
Net P&L
+₹139.95 (+3.47%)
Ventura
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Jun 29 3:51 AM

Update
Trade Entered
Entry Price
₹4,036.15
Ripper @ripper
Today 2:51 AM

Update
Exited
Exit Price
₹4,176.1
Net P&L
+₹139.95 (+3.47%)
N
Reputation: 3,789 • Jun 18 1:48 AM
Buy Pfizer; target of Rs 4705: ICICI Securities
ICICI Securities is bullish on Pfizer recommended buy rating on the stock with a target price of Rs 4705 in its research report dated June 15, 2020.
Moneycontrol
Like
Reply
N
Reputation: 3,789 • Jun 18 1:21 AM
India must manufacture more APIs locally, depend less on China: Experts
India, the worlds third-largest drug producer by volumes, imports 70% of its APIs from China. For some APIs, especially antibiotics, dependence on China is over 90%. Indias top drug makers, including Dr Reddys, Lupin, Glenmark, Mylan, Zydus and Pfizer are dependent on China for APIs.
The Economic Times
Like
Reply
N
Reputation: 3,789 • Jun 16 8:16 AM
Buy Pfizer, target price Rs 4,705: ICICI Securities
The brokerage believes that the difference between primary and secondary sales would normalise in the coming quarters. However, revenue would remain subdued in the near term.
The Economic Times
Like
Reply
N
Reputation: 3,789 • Jun 16 2:58 AM
Pfizer Standalone March 2020 Net Sales at Rs 502.01 crore, down 6.28% Y-o-Y
Moneycontrol
Like
Reply
T
Reputation: 10,883 • Jun 15 1:01 AM

**Pfizer - Q4 FY20 (Audited –Cons)**
CMP: 4,078
Total revenue from operations 502 Cr
536 Cr (-6.35%) YoY | 538 Cr (-6.65%) QoQ
Year ending revenue: 2,152 Cr Vs. 2,082 Cr (3.34%)
Net Profit of 103 Cr
109 Cr (-1.92%) YoY 139 Cr (-21.59%) QoQ
Year ending Net profit: 509 ...
Read more...
Like
Reply
N
Reputation: 3,789 • Jun 15 12:46 PM
Pfizer Q4 results: Net profit declines 6% to Rs 103 crore
The company had posted a net profit of Rs 109.47 crore in the corresponding period of the previous fiscal.
The Economic Times
Like
Reply

PFIZER: Q4 SL NET PROFIT 1.03B RUPEES VS 1.09B (YOY); EST 1.5B
PFIZER: Q4 REVENUE 5.02B RUPEES VS 5.36B (YOY) 15:00:03
PFIZER: RECOMMENDED DIVIDEND OF RUPEES 10/SHARE
Like
Reply

**Pfizer - Q4 FY20 (Audited –Cons)**
CMP: 4,078
Total revenue from operations 502 Cr
536 Cr (-6.35%) YoY | 538 Cr (-6.65%) QoQ
Year ending revenue: 2,152 Cr Vs. 2,082 Cr (3.34%)
Net Profit of 103 Cr
109 Cr (-1.92%) YoY 139 Cr (-21.59%) QoQ
Year ending Net pro...
Read more...
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • PFIZER - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization15,274.76
    Enterprise Value13,362.42
    Price to Earnings27.77
    Price to Book Value5.07
    Return on Capital Employed0.2
    Return on Equity0.13
    Face Value10
    Dividend Yield0.01
  • PFIZER - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    31-Oct-19ICICIdirect.comBuy4,775
    13-Aug-19Nirmal BangAccumulate3,181
    9-May-18CentrumBuy2,900
    8-May-18ICICIdirect.comBuy3,000
    20-Dec-17ICICIdirect.comBuy2,444
    PFIZER Brokerage Price Target
  • PFIZER Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 2424542754125.14181.8
    Jul 13988.8400039603973.75
    Jun 3040504053.9539553963.8
    Jun 2941004139.2540164034.85
    Jun 264121416740804101.7
  • PFIZER Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹4,052.86
    30 Day Moving Average₹4,077.28
    50 Day Moving Average₹4,272.77
    100 Day Moving Average₹4,218.83
    200 Day Moving Average₹4,033.5
  • PFIZER - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,9691,966.270
    Operating Profit501350.120.43
    Profit Before Tax548516.840.06
    Net Income360336.780.07
  • PFIZER - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds3,0122,6830.12
    Total Liabilities9281,084-0.14
    Total Assets3,9403,7660.05
  • PFIZER - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity332328.80.01
    Cash from Investing Activity-238-249.68-0.05
    Cash from Financing Activity-110-82.590.33
    Net Cash Flow-17-3.473.9
  • PFIZER - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.10.1
    Return on Equity0.130.14
    Return on Capital Employed0.20.21
  • PFIZER - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.06
    3 Year CAGR Growth in Operating Profit0.65
    3 Year CAGR Growth in EBIDTA0.66
    3 Year CAGR Growth in Net Income2.59
    3 Yr CAGR Growth - Diluted EPS2.59
  • PFIZER - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.88
    5 Year CAGR Growth in Operating Profit1.72
    5 Year CAGR Growth in EBIDTA-0.13
    5 Year CAGR Growth in Net Income-0.28
    3 Yr CAGR Growth - Diluted EPS-0.53
  • PFIZER - Recent News

    keyboard_arrow_down
    NewsBot
    Today 8:06 AM
    Rupee posts biggest single day gain against dollar since April 23
    The Economic Times
    NewsBot
    Today 3:11 AM
    Gold prices today ease amid upbeat economic data, optimism over vaccine
    The Economic Times
    NewsBot
    Today 2:36 AM
    Asian stocks rise on vaccine hopes, eyes on US payrolls
    The Economic Times
    NewsBot
    Today 1:26 AM
    Dollar on defensive as upbeat data dulls safe-haven appeal
    The Economic Times
    NewsBot
    Yesterday 5:01 AM
    BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial
    The Economic Times
    NewsBot
    Jun 18 1:48 AM
    Buy Pfizer; target of Rs 4705: ICICI Securities
    Moneycontrol
    NewsBot
    Jun 18 1:21 AM
    India must manufacture more APIs locally, depend less on China: Experts
    The Economic Times
    NewsBot
    Jun 16 2:58 AM
    Pfizer Standalone March 2020 Net Sales at Rs 502.01 crore, down 6.28% Y-o-Y
    Moneycontrol
    NewsBot
    Jun 15 12:46 PM
    Pfizer Q4 results: Net profit declines 6% to Rs 103 crore
    The Economic Times
    NewsBot
    Jun 15 9:23 AM
    Pfizer Q4 profit dips 6% to Rs 103 crore, operating margin contracts
    Moneycontrol
  • PFIZER - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020